Skip to main content

Client News

DEBx Medical Receives CE Mark and ISO 13485 Certification for Debrichem® for Chemical Debridement

25th February 2021

Marinomed Biotech AG announces positive clinical data for Carragelose lozenges against respiratory viruses including SARS-CoV-2

24th February 2021

RedHill Biopharma Announces Planned Expansion of Opaganib Global Phase 2/3 COVID-19 Study to the U.S.

23rd February 2021

XPhyto builds commercial team to launch 25-minute COVID-19 RT-PCR test

22nd February 2021

CENTOGENE GmbH: CENTOGENE führt Studie zur Untersuchung des SARS-CoV-2-Infektionsrisikos im Öffentlichen Personen-Nahverkehr in Zusammenarbeit mit der Charité Research Organisation durch

22nd February 2021

Marinomed Biotech AG shares positive clinical trial results for iota-carrageenan nasal spray in the prevention of COVID-19

19th February 2021

RedHill Biopharma Strengthens Partnership with Cosmo Pharmaceuticals with Manufacturing Agreements for Movantik and RHB-204

18th February 2021

CENTOGENE GmbH: Science Meets Culture: CENTOGENE’s Rare Disease Day 2021 Activities

18th February 2021

Marinomed Biotech AG publishes new supporting data on the in vitro efficacy of Carragelose® against SARS-CoV-2

18th February 2021

RedHill Biopharma Announces First Patient Dosed in U.S. Phase 2/3 COVID-19 Outpatient Study with RHB-107

17th February 2021